Britons are facing some of the most severe medicine shortages on record, impacting essential treatments for conditions ranging from epilepsy and high blood pressure to pancreatic cancer. According to the National Pharmacy Association (NPA), these supply chain disruptions—which have left some patients rationing medication or skipping meals—pose a direct risk to patient safety. The crisis has seen emergency Serious Shortage Protocols (SSPs) for medications like HRT drug Estradot and the digestive enzyme Creon extended until July 10, marking a record duration for such measures.
Why are common medicines in short supply?
Multiple factors are driving the current instability in the UK pharmaceutical supply chain. The NPA reports that geopolitical volatility, including the ongoing conflict in the Middle East, has strained international supply lines. These external pressures are compounded by domestic issues, including a lack of raw ingredients, manufacturing delays, and a UK medicines budget that often trails behind other EU nations, making the market less competitive for global suppliers. According to the NPA, these combined forces have led to price hikes for staple items like paracetamol and hay fever treatments.
How are patients managing the lack of medication?
The impact on individuals is significant, with many forced to adopt extreme measures to survive. Bryony Thomas, a 48-year-old pancreatic cancer survivor, reports that she has been forced to ration Creon—a vital digestive enzyme—for two years. During a three-month period where the drug was unavailable, Thomas reduced her protein and fat intake to cope with the lack of digestive support. She describes the current system as “stressful,” noting that patients are frequently left to drive between pharmacies or spend hours on the phone attempting to locate stock. Some patients have even turned to social media groups to trade life-saving medication, a trend fueled by the inability to source prescriptions through traditional pharmacy channels.
Current legislation in the UK prevents pharmacists from substituting a prescribed medicine for a safe, available alternative without explicit GP approval. Olivier Picard, chair of the NPA, is calling for an urgent legislative amendment to allow pharmacists more flexibility to substitute drugs when shortages occur.
What is the official response to the crisis?
Health leaders are pushing for systemic reform to address the frequency and duration of these shortages. The Royal College of GPs (RCGP) has highlighted the administrative burden placed on primary care, as doctors must frequently alter prescriptions to match available supply. Prof. Victoria Tzortziou Brown, president of the RCGP, emphasizes that resolving the underlying causes of these shortages is essential to prevent further patient distress. In response, a Department of Health and Social Care spokesperson stated that the “overwhelming majority” of licensed medicines remain in good supply, and the government is currently investing in domestic manufacturing to bolster resilience.
Future trends: Will medicine shortages continue?
Industry experts suggest that without a centralized approach, supply volatility will likely remain a fixture of the healthcare landscape. The NPA is advocating for a national taskforce, comprising wholesalers, manufacturers, and clinicians, to improve data sharing and supply chain management. This weekend, over 1,000 pharmacists and GPs are scheduled to meet in Birmingham to discuss these challenges and potential solutions, including a more proactive information-sharing network to track stock levels in real time. For patients like Thomas, the proposed solution is even more direct: she is calling for a central distribution mechanism to reclaim and redistribute medication from patients who have passed away, rather than allowing those supplies to be destroyed.
Frequently Asked Questions
What should I do if my pharmacy doesn’t have my prescription?
Speak with your pharmacist about whether a Serious Shortage Protocol (SSP) is in place for your medication, or contact your GP to discuss potential alternative treatments.
Why can’t my pharmacist just give me a different brand?
Under current UK law, pharmacists are restricted in their ability to substitute medicines. They must usually obtain authorization from a prescriber to change the specific drug or dosage provided.
Is the medicine shortage only happening in the UK?
No, global supply chain issues and ingredient shortages affect many countries, though the NPA notes that the UK’s specific medicine budget and procurement strategies can influence local availability compared to EU neighbors.
Are you or a family member struggling to access essential medication? Share your experience in the comments below or subscribe to our health newsletter for the latest updates on NHS supply chain developments.
